Long-term immune profiling of COVID-19 recovered patients: effects of disease severity and vaccination
Frontiers in Immunology · 10.04.2026 · 17
DOI: 10.3389/fimmu.2026.1699992 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Immunology, online erschienen am 10.04.2026. Verfasst von Thomas F Marandu und 12 weiteren Autor:innen. Beteiligte Einrichtung: University of Dar es Salaam-Mbeya College of Health and Allied Sciences, Mbeya, Tanzania. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, COVID-19 Vaccines. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The COVID-19 pandemic caused varied disease outcomes globally, with individuals experiencing severe, non-severe, or no disease. Immune responses generated post-exposure to SARS-CoV-2 play a critical role in protecting against severe COVID-19 upon re-infection. This study aimed to analyze immune-cell phenotypes and functions in COVID-19 Recovered Patients (C-19RPs) from varying disease severities.
Objective
To compare the immune-cell phenotypes and functions in C-19RPs from different forms of the disease, more than six months post-infection.
Methods
Between September 2021 and July 2023, 101 C-19RPs with hospital data (median age 31) were recruited from Mbeya Zonal Referral Hospital, Tanzania. In addition, seven uninfected and 19 Actively Infected Patients (AIPs) (median age 34 and 58.5, respectively) were included as controls. Blood samples were collected for SARS-CoV-2 serology, immune and genomic analysis, whereas demographic and vaccination data were gathered through a questionnaire.
Results
Serum anti-SARS-CoV-2 levels were similar between severe and non-severe C-19RPs but significantly higher in vaccinated non-severe cases than in unvaccinated ones. Severe C-19RPs and AIPs showed a trend towards decreased switched memory B cells. Frequencies of T-cell subsets were broadly similar across groups, but AIPs had increased central memory and decreased effector memory and effector CD4 T cells. T-cell responses to SARS-CoV-2 nucleocapsid peptides were not affected, but severe C-19RPs had increased CD8 cytokine responses and degranulation upon stimulation with Staphylococcus enterotoxin B (SEB). The frequency of CD56Dim_CD16Bright NK subsets was high in C-19RPs, while CD56Dim_CD16Neg subsets were reduced only in severe C-19RPs. DNA sequence analysis of the HLA from 18 C-19RPs and five uninfected participants revealed 11 and 20 alleles, which were exclusively found in severe and non-severe C-19RPs, respectively.
Conclusion
COVID-19 vaccination was particularly beneficial for non-severe C-19RPs, highlighting the benefits of vaccination in this group. Frequencies of B and NK cell subsets were long-term altered in the C-19RPs, while CD4 T-cell subset alterations were only in the AIPs. The enhanced T-cell response to SEB in the severe C-19RPs suggests potential long-term T-cell hyperresponsiveness, warranting further research. The unique HLA alleles exclusively found in either severe or non-severe C-19RPs may require additional exploration to confirm their association with disease severity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Dar es Salaam-Mbeya College of Health and Allied Sciences, Mbeya, Tanzania.
- National Institute for Medical Research -Mbeya Medical Research Centre, Mbeya, Tanzania.
- Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania.
- Tanzania Human Genetics Organization, Dar es Salaam, Tanzania.
- Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
- Mbeya Zonal Referral Hospital, Mbeya, Tanzania.
Zitieren
APA
Marandu, T. F., Sudi, L., Mbwele, B., Kiula, A., Alimohamed, M. Z., Sylvester, P., Msangi, S., Mgaya, R., Olomi, W., Ngowi, B., Ngatunga, C., Mwakyula, I. H., & Chachage, M. (2026). Long-term immune profiling of COVID-19 recovered patients: effects of disease severity and vaccination. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1699992
Vancouver
Marandu TF, Sudi L, Mbwele B, Kiula A, Alimohamed MZ, Sylvester P, et al. Long-term immune profiling of COVID-19 recovered patients: effects of disease severity and vaccination. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1699992
BibTeX
@article{Marandu2026,
author = {Marandu, Thomas F and Sudi, Lwitiho and Mbwele, Bernard and Kiula, Abdilahi and Alimohamed, Mohamed Zahir and Sylvester, Pauline and Msangi, Stephen and Mgaya, Regino and Olomi, Willyhelmina and Ngowi, Bernard and Ngatunga, Cecilia and Mwakyula, Issakwisa Habakkuk and Chachage, Mkunde},
title = {Long-term immune profiling of COVID-19 recovered patients: effects of disease severity and vaccination},
journal = {Frontiers in Immunology},
year = {2026},
volume = {17},
doi = {10.3389/fimmu.2026.1699992}
}
EUVIMED